Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Court

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|April 15, 2014
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypesDavid W Haas, Awewura Kwara, Danielle M Richardson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressantsL M Hesse, K Venkatakrishnan, M H Court, et al.
Pharmacogenetics|April 15, 2004
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomesLeah M Hesse, Ping He, Soundararajan Krishnaswamy, et al.
American Journal of Veterinary Research|March 4, 2009
Effects of dietary soy isoflavones on health, steroidogenesis, and thyroid gland function in dogsRosario Cerundolo, Kathy E Michel, Michael H Court, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteersAwewura Kwara, Karen T Tashima, Julie B Dumond, et al.
Pharmacotherapy|January 15, 2014
Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and induction of efavirenz clearanceAwewura Kwara, Lei Cao, Hongmei Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoformsM H Court, S X Duan, L L von Moltke, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 15, 2013
The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failureMichael H Court, Marina Freytsis, Xueding Wang, et al.
The Journal of Pharmacy and Pharmacology|January 18, 2011
Mechanism of cytochrome P450-3A inhibition by ketoconazoleDavid J Greenblatt, Yanli Zhao, Karthik Venkatakrishnan, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidaseDavid J Greenblatt, Diane E Peters, Lauren E Oleson, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|April 15, 2014
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypesDavid W Haas, Awewura Kwara, Danielle M Richardson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressantsL M Hesse, K Venkatakrishnan, M H Court, et al.
Pharmacogenetics|April 15, 2004
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomesLeah M Hesse, Ping He, Soundararajan Krishnaswamy, et al.
American Journal of Veterinary Research|March 4, 2009
Effects of dietary soy isoflavones on health, steroidogenesis, and thyroid gland function in dogsRosario Cerundolo, Kathy E Michel, Michael H Court, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteersAwewura Kwara, Karen T Tashima, Julie B Dumond, et al.
Pharmacotherapy|January 15, 2014
Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and induction of efavirenz clearanceAwewura Kwara, Lei Cao, Hongmei Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoformsM H Court, S X Duan, L L von Moltke, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 15, 2013
The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failureMichael H Court, Marina Freytsis, Xueding Wang, et al.
The Journal of Pharmacy and Pharmacology|January 18, 2011
Mechanism of cytochrome P450-3A inhibition by ketoconazoleDavid J Greenblatt, Yanli Zhao, Karthik Venkatakrishnan, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidaseDavid J Greenblatt, Diane E Peters, Lauren E Oleson, et al.
Pageof 21